HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of ACE, ACE2 and UTS2 polymorphisms with essential hypertension in Han and Dongxiang populations from north-western China.

Abstract
To assess the significance of polymorphisms of the genes for angiotensin-converting enzyme (ACE), angiotensin-converting enzyme 2 (ACE2) and urotensin II (UTS2) as risk factors for essential hypertension in two populations from north-western China, we enrolled 198 patients with essential hypertension and 131 healthy controls from the Han population and 120 patients with essential hypertension and 102 healthy controls from the Dongxiang population. Polymerase chain reaction (PCR) and PCR-restriction fragment length polymorphism were used to analyse gene polymorphisms. The results provided evidence that genetic variants of UTS2 and ACE2 may play a role in the development of essential hypertension in these populations. Polymorphisms of ACE were not associated with essential hypertension in either population. This is the first report showing that the S89N single-nucleotide polymorphism of the UTS2 gene is associated with essential hypertension.
AuthorsL Yi, Y H Gu, X L Wang, L Z An, X D Xie, W Shao, L Y Ma, J R Fang, Y D An, F Wang, D L Zhang
JournalThe Journal of international medical research (J Int Med Res) 2006 May-Jun Vol. 34 Issue 3 Pg. 272-83 ISSN: 0300-0605 [Print] England
PMID16866021 (Publication Type: Journal Article)
Chemical References
  • Urotensins
  • urotensin II
  • Peptidyl-Dipeptidase A
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2
Topics
  • Adult
  • Aged
  • Angiotensin-Converting Enzyme 2
  • Case-Control Studies
  • China
  • Female
  • Genetics, Population
  • Humans
  • Hypertension (enzymology, genetics)
  • Male
  • Middle Aged
  • Peptidyl-Dipeptidase A (genetics)
  • Polymorphism, Single Nucleotide
  • Risk Factors
  • Urotensins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: